ContextVision Past Earnings Performance
Past criteria checks 3/6
ContextVision has been growing earnings at an average annual rate of 11.6%, while the Healthcare Services industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 9.3% per year. ContextVision's return on equity is 22.8%, and it has net margins of 16%.
Key information
11.6%
Earnings growth rate
11.7%
EPS growth rate
| Healthcare Services Industry Growth | 2.9% |
| Revenue growth rate | 9.3% |
| Return on equity | 22.8% |
| Net Margin | 16.0% |
| Next Earnings Update | 02 Feb 2025 |
Recent past performance updates
Recent updates
There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings
Sep 02
ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Mar 11ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear
Feb 22ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 18Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)
Jan 26When Should You Buy ContextVision AB (publ) (OB:CONTX)?
Jun 22Is There Now An Opportunity In ContextVision AB (publ) (OB:CONTX)?
Jun 16Why ContextVision AB (publ) (OB:CONTX) Could Be Worth Watching
Mar 08Do ContextVision's (OB:CONTX) Earnings Warrant Your Attention?
Apr 19ContextVision AB (publ)'s (OB:CONTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 13Here's What ContextVision AB (publ)'s (OB:CONTX) Shareholder Ownership Structure Looks Like
Feb 14
ContextVision (OB:CONTX) Shareholders Have Enjoyed A Whopping 664% Share Price Gain
Jan 19Are ContextVision's (OB:CONTX) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 24Are Robust Financials Driving The Recent Rally In ContextVision AB (publ)'s (OB:COV) Stock?
Nov 28Revenue & Expenses Breakdown
How ContextVision makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 135 | 22 | 37 | 0 |
| 30 Jun 24 | 138 | 26 | 36 | 0 |
| 31 Mar 24 | 138 | 33 | 31 | 0 |
| 31 Dec 23 | 133 | 33 | 28 | 0 |
| 30 Sep 23 | 135 | 37 | 31 | 0 |
| 30 Jun 23 | 130 | 36 | 29 | 0 |
| 31 Mar 23 | 128 | 36 | 27 | 0 |
| 31 Dec 22 | 123 | 33 | 26 | 0 |
| 30 Sep 22 | 117 | 34 | 18 | 0 |
| 30 Jun 22 | 115 | 37 | 16 | 0 |
| 31 Mar 22 | 106 | 35 | 13 | 0 |
| 31 Dec 21 | 100 | 35 | 10 | 0 |
| 30 Sep 21 | 94 | 53 | 4 | 0 |
| 30 Jun 21 | 90 | 42 | 6 | 0 |
| 31 Mar 21 | 86 | 35 | 8 | 0 |
| 31 Dec 20 | 95 | 38 | 10 | 0 |
| 30 Sep 20 | 99 | 8 | 19 | 0 |
| 30 Jun 20 | 100 | 10 | 20 | 0 |
| 31 Mar 20 | 103 | 13 | 20 | 0 |
| 31 Dec 19 | 95 | 7 | 21 | 0 |
| 30 Sep 19 | 95 | 14 | 23 | 0 |
| 30 Jun 19 | 94 | 11 | 25 | 0 |
| 31 Mar 19 | 93 | 5 | 30 | 0 |
| 31 Dec 18 | 91 | -1 | 33 | 0 |
| 30 Sep 18 | 85 | -2 | 32 | 0 |
| 30 Jun 18 | 82 | -3 | 30 | 0 |
| 31 Mar 18 | 82 | -2 | 29 | 0 |
| 31 Dec 17 | 81 | -2 | 28 | 0 |
| 30 Sep 17 | 83 | -1 | 28 | 0 |
| 30 Jun 17 | 85 | 1 | 28 | 0 |
| 31 Mar 17 | 81 | 0 | 26 | 0 |
| 31 Dec 16 | 82 | 4 | 23 | 0 |
| 30 Sep 16 | 76 | 3 | 21 | 0 |
| 30 Jun 16 | 73 | 4 | 19 | 0 |
| 31 Mar 16 | 72 | 5 | 18 | 0 |
| 31 Dec 15 | 72 | 5 | 18 | 0 |
| 30 Sep 15 | 70 | 5 | 17 | 0 |
| 30 Jun 15 | 67 | 4 | 18 | 0 |
| 31 Mar 15 | 65 | 5 | 18 | 0 |
| 31 Dec 14 | 64 | 5 | 19 | 0 |
| 30 Sep 14 | 64 | 8 | 19 | 0 |
| 30 Jun 14 | 65 | 9 | 18 | 0 |
| 31 Mar 14 | 63 | 5 | 19 | 0 |
Quality Earnings: CONTX has high quality earnings.
Growing Profit Margin: CONTX's current net profit margins (16%) are lower than last year (27.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CONTX's earnings have grown by 11.6% per year over the past 5 years.
Accelerating Growth: CONTX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CONTX had negative earnings growth (-40.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (3.6%).
Return on Equity
High ROE: CONTX's Return on Equity (22.8%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 23:41 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ContextVision AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tomas Skeivys | Norne Securities AS |
| Juste Subataviciute | Norne Securities AS |
| Christian Lee | Pareto Securities |